Clinical Trial Update: Efficacy of a Probiotic Blend to Reduce Gastrointestinal Symptoms in Patients With Irritable Bowel Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a probiotic blend for reducing gastrointestinal symptoms in irritable bowel syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Probiotic blend

Snippet

Sponsor: Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: UNKNOWN